Source:http://linkedlifedata.com/resource/pubmed/id/15643546
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2005-1-11
|
pubmed:abstractText |
Previous investigations have indicated that rutaecarpine activates the vanilloid receptor to evoke calcitonin gene-related peptide (CGRP) release. CGRP has been shown to alleviate cardiac anaphylactic injury. In the present study, the effect of rutaecarpine on cardiac anaphylaxis was examined. Challenge of presensitized guinea-pig hearts with a specific antigen caused marked decreases in coronary flow (CF), left ventricular pressure (LVP) and its derivatives (+/- dp/dt(max)), an increase in heart rate, and prolongation of the P-R interval. Rutaecarpine (0.3 or 1 microM) markedly increased the content of calcitonin gene-related peptide (CGRP) in the coronary effluent and decreased the content of tumor necrosis factor-alpha (TNF-alpha) in myocardial tissues concomitantly with a significant improvement of cardiac function and alleviation of the extension of the P-R interval. Rutaecarpine at the concentration of 1 microM also inhibited the sinus tachycardia. The protective effects of rutaecarpine on cardiac anaphylaxis were abolished by CGRP (8-37), a selective CGRP receptor antagonist. These results suggest that the protective effects of rutaecarpine on cardiac anaphylactic injury are related to inhibition of TNF-alpha production by stimulation of CGRP release.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Alkaloids,
http://linkedlifedata.com/resource/pubmed/chemical/Cardiotonic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Indole Alkaloids,
http://linkedlifedata.com/resource/pubmed/chemical/Quinazolines,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/rutecarpine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0032-0943
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
70
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1135-9
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15643546-Alkaloids,
pubmed-meshheading:15643546-Anaphylaxis,
pubmed-meshheading:15643546-Animals,
pubmed-meshheading:15643546-Blood Pressure,
pubmed-meshheading:15643546-Cardiotonic Agents,
pubmed-meshheading:15643546-Coronary Vessels,
pubmed-meshheading:15643546-Evodia,
pubmed-meshheading:15643546-Female,
pubmed-meshheading:15643546-Guinea Pigs,
pubmed-meshheading:15643546-Heart,
pubmed-meshheading:15643546-Heart Rate,
pubmed-meshheading:15643546-Indole Alkaloids,
pubmed-meshheading:15643546-Male,
pubmed-meshheading:15643546-Myocardium,
pubmed-meshheading:15643546-Phytotherapy,
pubmed-meshheading:15643546-Quinazolines,
pubmed-meshheading:15643546-Tumor Necrosis Factor-alpha
|
pubmed:year |
2004
|
pubmed:articleTitle |
Protective effects of rutaecarpine in cardiac anaphylactic injury is mediated by CGRP.
|
pubmed:affiliation |
Department of Pharmacology, School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, P. R. China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|